My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Will Evaluating Dose to Coronary Arteries Improve Risk Estimates?
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S126
Assessment of Biochemical Outcomes with Increasing Dose Escalation in Localized Prostate Cancer (PCa) Treated with Precision Image Guided Radiation Therapy (IGRT).
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E228-E229
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):248-50
Breast. 2016 Jul 30;29:120-122
Ann Palliat Med. 2016 Jul;5(3):209-17
Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.
Lancet Oncol. 2016 Apr;17(4):e163-72
PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer.
Cancer. 2016 May 24;
Book. 2015 11 01
Book. 2015 11 01
Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):440-9
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)